Neuroprotection by curcumin: A review on brain delivery strategies

被引：68

作者：

Askarizadeh, Anis ^{[1
]}

Barreto, George E. ^{[2
,3
]}

Henney, Neil C. ^{[4
]}

Majeed, Muhammed ^{[5
]}

Sahebkar, Amirhossein ^{[6
,7
,8
]}

机构：

[1] Mashhad Univ Med Sci, Nanotechnol Res Ctr, Pharmaceut Technol Inst, Mashhad, Razavi Khorasan, Iran

[2] Univ Limerick, Dept Biol Sci, Limerick, Ireland

[3] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile

[4] Liverpool John Moores Univ, Pharm & Biomol Sci, Liverpool, Merseyside, England

[5] Sabinsa Corp, East Windsor, NJ USA

[6] FDA, Halal Res Ctr IRI, Tehran, Iran

[7] Mashhad Univ Med Sci, Biotechnol Res Ctr, Pharmaceut Technol Inst, Mashhad, Razavi Khorasan, Iran

[8] Mashhad Univ Med Sci, Sch Pharm, Mashhad, Razavi Khorasan, Iran

来源：

INTERNATIONAL JOURNAL OF PHARMACEUTICS | 2020年 / 585卷

关键词：

Neurodegeneration; Curcumin; Blood-brain barrier; Nanotechnology; Drug delivery; SOLID LIPID NANOPARTICLES; IN-VITRO EVALUATION; INTRANASAL MUCOADHESIVE MICROEMULSIONS; LOADED PLGA NANOPARTICLES; BLOCK-COPOLYMER MICELLES; LOW-DENSITY-LIPOPROTEIN; DRUG-DELIVERY; MAGNETIC NANOPARTICLES; POLYMERIC NANOPARTICLES; ANTIINFLAMMATORY DRUGS;

D O I：

10.1016/j.ijpharm.2020.119476

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Neurodegenerative diseases are a major global public health concern in the elderly population but therapeutic options are limited. Curcumin is a hydrophobic polyphenol extracted from the dried rhizomes of Curcuma longa L. and shows good potential for the treatment of neurodegenerative diseases and brain tumors. The blood-brain barrier (BBB) is the major obstacle for the delivery of curcumin into the brain, limiting its therapeutic potential. The development of promising approaches to facilitate curcumin transportation across the BBB may resolve some of the problems associated with drug delivery. Studies have shown nano delivery of curcumin can improve a number of outcome measures in neurodegenerative diseases. The present review highlights current and emerging strategies to facilitate curcumin permeation across the BBB for the treatment of various neurodegenerative diseases.

引用

页数：19

共 166 条

[1] Structure and function of the blood-brain barrier [J].

Abbott, N. Joan ;

Patabendige, Adjanie A. K. ;

Dolman, Diana E. M. ;

Yusof, Siti R. ;

Begley, David J. .

NEUROBIOLOGY OF DISEASE, 2010, 37 (01) :13-25

[2] Astrocyte-endothelial interactions at the blood-brain barrier [J].

Abbott, NJ ;

Rönnbäck, L ;

Hansson, E .

NATURE REVIEWS NEUROSCIENCE, 2006, 7 (01) :41-53

[3] Biodegradable Neuro-Compatible Peptide Hydrogel Promotes Neurite Outgrowth, Shows Significant Neuroprotection, and Delivers Anti-Alzheimer Drug [J].

Adak, Anindyasundar ;

Das, Gaurav ;

Barman, Surajit ;

Mohapatra, Saswat ;

Bhunia, Debmalya ;

Jana, Batakrishna ;

Ghosh, Surajit .

ACS APPLIED MATERIALS & INTERFACES, 2017, 9 (06) :5067-5076

[4] Recent advancements in liposomes targeting strategies to cross blood-brain barrier (BBB) for the treatment of Alzheimer's disease [J].

Agrawal, Mukta ;

Ajazuddin ;

Tripathi, Dulal K. ;

Saraf, Swarnlata ;

Saraf, Shailendra ;

Antimisiaris, Sophia G. ;

Mourtas, Spyridon ;

Hammarlund-Udenaes, Margareta ;

Alexander, Amit .

JOURNAL OF CONTROLLED RELEASE, 2017, 260 :61-77

[5] RETRACTED: PNIPAM nanoparticles for targeted and enhanced nose-to-brain delivery of curcuminoids: UPLC/ESI-Q-ToF-MS/MS-based pharmacokinetics and pharmacodynamic evaluation in cerebral ischemia model (Retracted Article) [J].

Ahmad, Niyaz ;

Ahmad, Iqbal ;

Umar, Sadiq ;

Iqbal, Zeenat ;

Samim, Mohd ;

Ahmad, Farhan Jalees .

DRUG DELIVERY, 2016, 23 (07) :2095-2114

[6] A comparative study of PNIPAM nanoparticles of curcumin, demethoxycurcumin, and bisdemethoxycurcumin and their effects on oxidative stress markers in experimental stroke [J].

Ahmad, Niyaz ;

Umar, Sadiq ;

Ashafaq, Mohammad ;

Akhtar, Mohd ;

Iqbal, Zeenat ;

Samim, Mohd ;

Ahmad, Farhan Jalees .

PROTOPLASMA, 2013, 250 (06) :1327-1338

[7] Progress and perspectives of brain-targeting lipid-based nanosystems via the nasal route in Alzheimer's disease [J].

Akel, Hussein ;

Ismail, Ruba ;

Csoka, Ildiko .

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2020, 148 :38-53

[8] Biodistribution of polysorbate 80-coated doxorubicin-loaded [14C]-poly(butyl cyanoacrylate) nanoparticles after intravenous administration to glioblastoma-bearing rats [J].

Ambruosi, A ;

Khalansky, AS ;

Yamamoto, H ;

Gelperina, SE ;

Begley, DJ ;

Kreuter, J .

JOURNAL OF DRUG TARGETING, 2006, 14 (02) :97-105

[9] Recent progress in repositioning Alzheimer's disease drugs based on a multitarget strategy [J].

Amelia Santos, M. ;

Chand, Karam ;

Chaves, Silvia .

FUTURE MEDICINAL CHEMISTRY, 2016, 8 (17) :2113-2142

[10] Bioavailability of curcumin: Problems and promises [J].

Anand, Preetha ;

Kunnumakkara, Ajaikumar B. ;

Newman, Robert A. ;

Aggarwal, Bharat B. .

MOLECULAR PHARMACEUTICS, 2007, 4 (06) :807-818

← 1 2 3 4 5 6 7 8 9 10 →